Scarica l'app Stockscreener
32.17
3.08%
0.96
Dopo l'orario di chiusura:
32.34
0.17
+0.53%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ALKS Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$31.21
Aprire:
$31.39
Volume 24 ore:
1.69M
Relative Volume:
0.88
Capitalizzazione di mercato:
$5.31B
Reddito:
$1.51B
Utile/perdita netta:
$333.35M
Rapporto P/E:
16.50
EPS:
1.95
Flusso di cassa netto:
$315.22M
1 W Prestazione:
+3.81%
1M Prestazione:
+19.28%
6M Prestazione:
+19.15%
1 anno Prestazione:
+11.28%
Intervallo 1D:
$31.25
$32.31
Intervallo di 1 settimana:
$30.70
$32.31
Portata 52W:
$25.16
$36.45
Alkermes Plc Stock (ALKS) Company Profile
Nome
Alkermes Plc
Settore
Telefono
00-353-1-772-8000
Indirizzo
CONNAUGHT HOUSE, DUBLIN 4
Confronta ALKS con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ALKS
Alkermes Plc
|
32.17 | 5.15B | 1.51B | 333.35M | 315.22M | 1.95 |
|
ZTS
Zoetis Inc
|
142.26 | 62.54B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.72 | 43.30B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.08 | 40.08B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.02 | 22.98B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
440.06 | 19.90B | 3.08B | 1.24B | 1.07B | 25.61 |
Alkermes Plc Stock (ALKS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-26 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2025-09-03 | Iniziato | Wells Fargo | Overweight |
| 2025-07-15 | Iniziato | Goldman | Buy |
| 2025-06-17 | Aggiornamento | UBS | Neutral → Buy |
| 2025-05-28 | Iniziato | Needham | Buy |
| 2025-03-13 | Iniziato | RBC Capital Mkts | Sector Perform |
| 2025-03-04 | Aggiornamento | UBS | Sell → Neutral |
| 2025-02-11 | Iniziato | Deutsche Bank | Buy |
| 2024-11-05 | Aggiornamento | Stifel | Hold → Buy |
| 2024-06-17 | Iniziato | TD Cowen | Buy |
| 2024-03-19 | Iniziato | Robert W. Baird | Outperform |
| 2024-02-20 | Downgrade | UBS | Neutral → Sell |
| 2023-11-20 | Ripresa | JP Morgan | Neutral |
| 2023-10-24 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2023-10-17 | Iniziato | UBS | Neutral |
| 2022-11-03 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2022-10-14 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2022-08-16 | Iniziato | Piper Sandler | Neutral |
| 2022-04-22 | Ripresa | Goldman | Buy |
| 2022-04-20 | Iniziato | Goldman | Buy |
| 2022-01-27 | Aggiornamento | Cantor Fitzgerald | Hold → Overweight |
| 2021-12-01 | Iniziato | Citigroup | Neutral |
| 2021-10-07 | Aggiornamento | Jefferies | Hold → Buy |
| 2021-09-02 | Downgrade | BofA Securities | Neutral → Underperform |
| 2020-10-15 | Aggiornamento | Mizuho | Neutral → Buy |
| 2020-07-30 | Downgrade | Goldman | Neutral → Sell |
| 2020-02-14 | Downgrade | BofA/Merrill | Buy → Neutral |
| 2020-02-14 | Reiterato | H.C. Wainwright | Neutral |
| 2020-02-14 | Downgrade | JP Morgan | Overweight → Neutral |
| 2020-02-06 | Iniziato | Mizuho | Neutral |
| 2020-01-31 | Aggiornamento | Wolfe Research | Underperform → Peer Perform |
| 2019-09-05 | Aggiornamento | Morgan Stanley | Underweight → Equal-Weight |
| 2019-07-15 | Aggiornamento | Goldman | Sell → Neutral |
| 2019-05-31 | Iniziato | H.C. Wainwright | Neutral |
| 2019-05-01 | Downgrade | Citigroup | Buy → Neutral |
| 2018-12-19 | Downgrade | Goldman | Neutral → Sell |
| 2018-12-14 | Iniziato | Wolfe Research | Underperform |
| 2018-12-13 | Downgrade | Credit Suisse | Outperform → Underperform |
| 2018-11-05 | Iniziato | Piper Jaffray | Neutral |
| 2018-08-07 | Iniziato | Stifel | Hold |
| 2018-06-21 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| 2018-06-06 | Iniziato | B. Riley FBR, Inc. | Buy |
| 2018-05-16 | Aggiornamento | Citigroup | Neutral → Buy |
| 2018-05-11 | Iniziato | BofA/Merrill | Buy |
Mostra tutto
Alkermes Plc Borsa (ALKS) Ultime notizie
Order flow analysis tools used on Alkermes plcDay Trade & AI Enhanced Execution Alerts - newser.com
Why Alkermes plc stock appeals to analystsTrade Analysis Summary & Comprehensive Market Scan Insights - newser.com
Is now a turning point for Alkermes plcQuarterly Portfolio Summary & Trade Opportunity Analysis - newser.com
Full technical analysis of Alkermes plc stock2025 Volume Leaders & Long-Term Capital Growth Ideas - newser.com
What technical models suggest about Alkermes plc’s comebackBear Alert & Verified Trade Idea Suggestions - newser.com
Is Alkermes plc a good long term investmentDouble Top/Bottom Patterns & Identify Safe Investments - earlytimes.in
Can Alkermes plc stock deliver strong Q4 earningsMarket Risk Summary & Fast Moving Market Watchlists - newser.com
Is Alkermes plc (8AK) stock cheap vs fundamentalsShort Setup & Fast Gain Stock Trading Tips - newser.com
Historical volatility pattern of Alkermes plc visualizedJuly 2025 Decliners & High Conviction Buy Zone Picks - newser.com
Ranking Alkermes plc among high performing stocks via toolsJuly 2025 Movers & Comprehensive Market Scan Insights - newser.com
Real time breakdown of Alkermes plc stock performance2025 Pullback Review & Advanced Technical Analysis Signals - newser.com
Alkermes Plc Experiences Revision in Stock Evaluation Amid Mixed Market Signals - Markets Mojo
How cyclical is Alkermes plc (8AK) stock compared to rivalsEarnings Overview Report & Fast Gaining Stock Strategy Reports - newser.com
Pattern recognition hints at Alkermes plc upside2025 Stock Rankings & Daily Market Momentum Tracking - newser.com
Will Alkermes plc (8AK) stock hit Wall Street targetsProduct Launch & AI Powered Market Entry Ideas - newser.com
Is Alkermes Plc (NASDAQ:ALKS) Trading At A 43% Discount? - 富途牛牛
Alkermes upgraded at RBC Capital Markets ahead of key catalyst - MSN
RBC Lifts Price Target on Alkermes to $45 From $44, Keeps Outperform Rating - MarketScreener
Do Options Traders Know Something About Alkermes Stock We Don't? - Yahoo Finance
Robeco Institutional Asset Management B.V. Buys 36,467 Shares of Alkermes plc $ALKS - MarketBeat
Substance Abuse Treatment Market Size, Growth Analysis 2031 - openPR.com
Is Alkermes plc (8AK) stock at risk of policy regulationGold Moves & Daily Entry Point Alerts - newser.com
Is Alkermes plc reversing from oversold territoryTrade Risk Assessment & Reliable Breakout Stock Forecasts - newser.com
Technical analysis overview for Alkermes plc stockMarket Weekly Review & Fast Exit/Entry Strategy Plans - newser.com
Alkermes Plc Experiences Evaluation Revision Amidst Mixed Market Signals and Performance Trends - Markets Mojo
Alkermes sued over alleged scheme to block generic Vivitrol - Reuters
Will Alkermes plc (8AK) stock benefit from Fed rate cuts2025 Market Overview & Comprehensive Market Scan Insights - newser.com
What candlestick patterns are forming on Alkermes plcJuly 2025 Patterns & Fast Gain Stock Trading Tips - newser.com
Alkermes Plc Hits Day High with Strong 10.58% Intraday Surge - Markets Mojo
Alkermes (ALKS) Added to Wells Fargo's Tactical Ideas List - GuruFocus
What analysts say about Alkermes plc 8AK stockPrice-to-Earnings Ratio Insights & Budget Friendly Capital Growth - earlytimes.in
What drives Alkermes plc stock priceMarket Breadth Indicators & Explosive Profit Trading - earlytimes.in
Alkermes Plc Azioni (ALKS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.42%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):